Despite these appeals, industry observers note that a swift return of the feature seems unlikely. Sources familiar with the matter suggest that without a settlement or a successful legal challenge, the blood oxygen sensor might not reappear until at least 2028, when key Masimo patents expire. This timeline aligns with insights from MacRumors, which detailed how Apple could potentially reactivate the feature via software updates post-patent expiration or through a favorable court ruling.